German pharmaceutical group Merck is seeking a partnership with an Iranian manufacturer to produce medicines in the country in a sign that western companies are putting their faith in President Hassan Rouhani’s reformist drive and an easing of international sanctions.
Dozens of European businesses have visited the country in recent months in anticipation of a thaw in relations over Iran’s nuclear programme that could rehabilitate the oil-rich country as a destination for business investment.
Iranian and western businessmen say some tentative deals have been prepared, ready for signature once the interim nuclear agreement struck in Geneva last month is implemented.
您已阅读29%（670字），剩余71%（1607字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。